Precigen (PGEN) Debt to Equity (2012 - 2026)
Precigen (PGEN) reported Debt to Equity of $4.62 for Q1 2026, up 3.72% quarter-over-quarter from $4.46 in Q4 2025.
Precigen (PGEN) Debt to Equity (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Debt to Equity data on file, last reported at $4.62 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $4.62, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $4.62 (changed N/A YoY), and the FY2025 annual result was $4.46, changed N/A from the prior year.
- Debt to Equity climbed to $4.62 in Q1 2026 per PGEN's latest filing, from $4.46 in the prior quarter.
- Over five years, Debt to Equity peaked at $4.62 in Q1 2026 and troughed at $0.08 in Q1 2023.
- A 4-year average of $2.63 and a median of $3.15 in 2022 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2022 and 2023: Debt to Equity jumped 221.27% in 2022, then tumbled 97.25% in 2023.
- A 4-year view of Debt to Equity shows it stood at $0.34 in 2022, then tumbled by 78.08% to $0.08 in 2023, then surged by 5837.11% to $4.46 in 2025, then climbed by 3.72% to $4.62 in 2026.
- Business Quant data shows PGEN's Debt to Equity at $4.62 in Q1 2026, $4.46 in Q4 2025, and $0.08 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 4.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.62 |
| Dec 31, 2025 | 4.46 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.34 |
| Jun 30, 2022 | 3.57 |
| Mar 31, 2022 | 2.72 |
| Dec 31, 2021 | 1.68 |
| Sep 30, 2021 | 1.37 |
| Jun 30, 2021 | 1.11 |
| Mar 31, 2021 | 1.00 |
| Dec 31, 2020 | 2.56 |
| Sep 30, 2020 | 3.32 |
| Jun 30, 2020 | 3.86 |
| Mar 31, 2020 | 2.18 |
| Dec 31, 2019 | 2.60 |
| Sep 30, 2019 | 0.94 |
| Jun 30, 2019 | -0.15 |
| Mar 31, 2019 | 0.65 |
| Dec 31, 2018 | 0.56 |
| Sep 30, 2018 | 0.33 |